SG11201908932SA - Process for making arylomyin ring analogs - Google Patents
Process for making arylomyin ring analogsInfo
- Publication number
- SG11201908932SA SG11201908932SA SG11201908932SA SG11201908932SA SG 11201908932S A SG11201908932S A SG 11201908932SA SG 11201908932S A SG11201908932S A SG 11201908932SA SG 11201908932S A SG11201908932S A SG 11201908932SA
- Authority
- SG
- Singapore
- Prior art keywords
- genentech
- san francisco
- california
- south san
- international
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D245/00—Heterocyclic compounds containing rings of more than seven members having two nitrogen atoms as the only ring hetero atoms
- C07D245/02—Heterocyclic compounds containing rings of more than seven members having two nitrogen atoms as the only ring hetero atoms not condensed with other rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K1/00—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length
- C07K1/06—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length using protecting groups or activating agents
- C07K1/061—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length using protecting groups or activating agents using protecting groups
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
- C07K7/64—Cyclic peptides containing only normal peptide links
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Molecular Biology (AREA)
- Biochemistry (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Genetics & Genomics (AREA)
- Biophysics (AREA)
- Oncology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Communicable Diseases (AREA)
- General Chemical & Material Sciences (AREA)
- Analytical Chemistry (AREA)
- Epidemiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Saccharide Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
Abstract
INTERNATIONAL APPLICATION PUBLISHED UNDER THE PATENT COOPERATION TREATY (PCT) (19) World Intellectual Property Organization International Bureau (43) International Publication Date 04 October 2018 (04.10.2018) W I PO I PCT omit °nolo monium mu Imo oimIE (10) International Publication Number WO 2018/183198 Al (51) International Patent Classification: C07D 245/02 (2006.01) A61P 31/04 (2006.01) A61K 31/395 (2006.01) (21) International Application Number: PCT/US2018/024351 (22) International Filing Date: 26 March 2018 (26.03.2018) (25) Filing Language: English (26) Publication Language: English (30) Priority Data: 62/477,268 27 March 2017 (27.03.2017) US (71) Applicant (for US only): GENENTECH, INC. [US/US]; 1 DNA Way, South San Francisco, California 94080 (US). (71) Applicant (for all designated States except US): F. HOFF- MANN-LA ROCHE AG [CH/CH]; Grenzacherstrasse 124, 4070 BASEL (CH). (72) Inventors: PETRONIJEVIC, Filip; c/o Genentech, Inc., 1 DNA Way, South San Francisco, California 94080 (US). LIM, Ngiap-Kie; c/o Genentech, Inc., 1 DNA Way, South San Francisco, California 94080 (US). WONG, Nicholas; c/o Genentech, Inc., 1 DNA Way, South San Francisco, Cal- ifornia 94080 (US). HONG, Allen; c/o Genentech, Inc., 1 DNA Way, South San Francisco, California 94080 (US). HOU, Haiyun; 1321 Orleans Street, Apt. 1814, Detroit, Michigan 48207 (US). LINGHU, Xin; c/o Genentech, Inc., 1 DNA Way, South San Francisco, California 94080 (US). GOSSELIN, Francis; c/o Genentech, Inc., 1 DNA Way, South San Francisco, California 94080 (US). (74) Agent: HALL, Robert C. et al.; c/o Genentech, Inc., 1 DNA Way, South San Francisco, California 94080 (US). (81) Designated States (unless otherwise indicated, for every kind of national protection available): AE, AG, AL, AM, AO, AT, AU, AZ, BA, BB, BG, BH, BN, BR, BW, BY, BZ, CA, CH, CL, CN, CO, CR, CU, CZ, DE, DJ, DK, DM, DO, DZ, EC, EE, EG, ES, FI, GB, GD, GE, GH, GM, GT, HN, HR, HU, ID, IL, IN, IR, IS, JO, JP, KE, KG, KH, KN, KP, KR, KW, KZ, LA, LC, LK, LR, LS, LU, LY, MA, MD, ME, MG, MK, MN, MW, MX, MY, MZ, NA, NG, NI, NO, NZ, OM, PA, PE, PG, PH, PL, PT, QA, RO, RS, RU, RW, SA, SC, SD, SE, SG, SK, SL, SM, ST, SV, SY, TH, TJ, TM, TN, TR, TT, TZ, UA, UG, US, UZ, VC, VN, ZA, ZM, ZW. (84) Designated States (unless otherwise indicated, for every kind of regional protection available): ARIPO (BW, GH, GM, KE, LR, LS, MW, MZ, NA, RW, SD, SL, ST, SZ, TZ, UG, ZM, ZW), Eurasian (AM, AZ, BY, KG, KZ, RU, TJ, TM), European (AL, AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LT, LU, LV, MC, MK, MT, NL, NO, PL, PT, RO, RS, SE, SI, SK, SM, TR), OAPI (BF, BJ, CF, CG, CI, CM, GA, GN, GQ, GW, KM, ML, MR, NE, SN, TD, TG). Declarations under Rule 4.17: as to applicant's entitlement to apply for and be granted a patent (Rule 4.17(ii)) as to the applicant's entitlement to claim the priority of the earlier application (Rule 4.17(iii)) Published: — with international search report (Art. 21(3)) (54) Title: PROCESS FOR MAKING ARYLOMYIN RING ANALOGS O c (57) : Methods for making an arylomycin ring of formula t or salts or solvates thereof, wherein R, R 1 , R 2 , R7, R8, R 9 , R 5 , R10 and t• —gi are as defined herein. R 3 , R, R 4 5 , R6,
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201762477268P | 2017-03-27 | 2017-03-27 | |
| PCT/US2018/024351 WO2018183198A1 (en) | 2017-03-27 | 2018-03-26 | Process for making arylomyin ring analogs |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| SG11201908932SA true SG11201908932SA (en) | 2019-10-30 |
Family
ID=61913697
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| SG11201908932S SG11201908932SA (en) | 2017-03-27 | 2018-03-26 | Process for making arylomyin ring analogs |
Country Status (16)
| Country | Link |
|---|---|
| US (2) | US11192924B2 (en) |
| EP (1) | EP3601240B1 (en) |
| JP (1) | JP7041687B2 (en) |
| KR (1) | KR102589474B1 (en) |
| CN (2) | CN110475766B (en) |
| AU (2) | AU2018243724B2 (en) |
| BR (1) | BR112019020112A2 (en) |
| CA (1) | CA3057997A1 (en) |
| ES (1) | ES2892173T3 (en) |
| HR (1) | HRP20211495T1 (en) |
| IL (1) | IL269532B (en) |
| MX (1) | MX2019011517A (en) |
| PL (1) | PL3601240T3 (en) |
| SG (1) | SG11201908932SA (en) |
| SI (1) | SI3601240T1 (en) |
| WO (1) | WO2018183198A1 (en) |
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP6873993B2 (en) | 2015-11-20 | 2021-05-19 | アールキューエックス ファーマシューティカルズ，インク． | Macrocycle broad-spectrum antibiotic |
| IL268483B2 (en) * | 2017-02-15 | 2024-02-01 | Rqx Pharmaceuticals Inc | Macrocyclic broad spectrum antibiotics |
| CR20210682A (en) * | 2019-05-28 | 2022-06-02 | Hoffmann La Roche | Macrocyclic broad spectrum antibiotics |
-
2018
- 2018-03-26 HR HRP20211495TT patent/HRP20211495T1/en unknown
- 2018-03-26 MX MX2019011517A patent/MX2019011517A/en unknown
- 2018-03-26 BR BR112019020112A patent/BR112019020112A2/en active Search and Examination
- 2018-03-26 SI SI201830418T patent/SI3601240T1/en unknown
- 2018-03-26 JP JP2019553110A patent/JP7041687B2/en active Active
- 2018-03-26 CN CN201880020965.3A patent/CN110475766B/en active Active
- 2018-03-26 AU AU2018243724A patent/AU2018243724B2/en active Active
- 2018-03-26 WO PCT/US2018/024351 patent/WO2018183198A1/en unknown
- 2018-03-26 SG SG11201908932S patent/SG11201908932SA/en unknown
- 2018-03-26 CN CN202311833909.0A patent/CN117777229A/en active Pending
- 2018-03-26 ES ES18716874T patent/ES2892173T3/en active Active
- 2018-03-26 EP EP18716874.5A patent/EP3601240B1/en active Active
- 2018-03-26 PL PL18716874T patent/PL3601240T3/en unknown
- 2018-03-26 CA CA3057997A patent/CA3057997A1/en active Pending
- 2018-03-26 KR KR1020197031578A patent/KR102589474B1/en active IP Right Grant
-
2019
- 2019-09-23 IL IL269532A patent/IL269532B/en unknown
- 2019-09-24 US US16/581,116 patent/US11192924B2/en active Active
-
2021
- 2021-11-02 US US17/517,103 patent/US11702452B2/en active Active
-
2022
- 2022-08-16 AU AU2022218486A patent/AU2022218486B2/en active Active
Also Published As
| Publication number | Publication date |
|---|---|
| SI3601240T1 (en) | 2021-11-30 |
| AU2022218486B2 (en) | 2023-09-28 |
| IL269532A (en) | 2019-11-28 |
| AU2018243724B2 (en) | 2022-07-28 |
| CA3057997A1 (en) | 2018-10-04 |
| WO2018183198A1 (en) | 2018-10-04 |
| US20220056078A1 (en) | 2022-02-24 |
| CN110475766B (en) | 2023-12-29 |
| JP2020512353A (en) | 2020-04-23 |
| PL3601240T3 (en) | 2021-12-20 |
| JP7041687B2 (en) | 2022-03-24 |
| AU2022218486A1 (en) | 2022-09-08 |
| US11192924B2 (en) | 2021-12-07 |
| IL269532B (en) | 2021-12-01 |
| KR102589474B1 (en) | 2023-10-16 |
| ES2892173T3 (en) | 2022-02-02 |
| MX2019011517A (en) | 2019-11-18 |
| HRP20211495T1 (en) | 2021-12-24 |
| BR112019020112A2 (en) | 2020-05-05 |
| KR20190133033A (en) | 2019-11-29 |
| CN117777229A (en) | 2024-03-29 |
| US20200255476A1 (en) | 2020-08-13 |
| AU2018243724A1 (en) | 2019-10-03 |
| US11702452B2 (en) | 2023-07-18 |
| CN110475766A (en) | 2019-11-19 |
| EP3601240B1 (en) | 2021-08-04 |
| EP3601240A1 (en) | 2020-02-05 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| SG11201809344QA (en) | Process for synthesizing 2-hydroxy-6-((2-(1-isopropyl-1h-pyrazol-5-yl)-pyridin-3-yl)methoxy)benzaldehyde | |
| SG11201906763RA (en) | Pyrrolo [1,2-b] pyridazine derivatives | |
| SG11201811564QA (en) | Methods of treating ovarian cancer | |
| SG11201900480YA (en) | Anti-tim-3 antibodies | |
| SG11201811491YA (en) | Quinazoline and indole compounds to treat medical disorders | |
| SG11201908567UA (en) | Modified cyclic dinucleotide compounds | |
| SG11201808622SA (en) | Chimeric receptors to flt3 and methods of use thereof | |
| SG11201809912UA (en) | Hybrid carriers for nucleic acid cargo | |
| SG11201900163PA (en) | Macrocycle kinase inhibitors | |
| SG11201804373VA (en) | Compositions and methods for immunooncology | |
| SG11201805044WA (en) | Compounds useful as kinase inhibitors | |
| SG11201909011PA (en) | Niraparib compositions | |
| SG11201906386XA (en) | Combination therapy involving diaryl macrocyclic compounds | |
| SG11201809625RA (en) | 1-tetrahydropyranylcarbonyl-2,3-dihydro-1h-indole compounds for treating cancer | |
| SG11201808237UA (en) | Substituted indole compound derivatives as dengue viral replication inhibitors | |
| SG11201808222RA (en) | Methods of treatment of cholestatic diseases | |
| SG11201908465QA (en) | Substituted indoline derivatives as dengue viral replication inhibitors | |
| SG11201909807TA (en) | Methods of manufacturing of niraparib | |
| SG11201900633XA (en) | Piperidine cxcr7 receptor modulators | |
| SG11202000333UA (en) | Bicyclic ketone compounds and methods of use thereof | |
| SG11201909680UA (en) | Phenyl-2-hydroxy-acetylamino-2-methyl-phenyl compounds | |
| SG11201906436VA (en) | Novel heterocyclic compound, its preparation method, and pharmaceutical composition comprising the same | |
| SG11201901228QA (en) | Chromatography method for quantifying a non-ionic surfactant in a composition comprising the non-ionic surfactant and a polypeptide | |
| SG11201908660RA (en) | N-substituted indole derivatives | |
| SG11201901673SA (en) | Imidazole derivatives and their use in the treatment of autoimmune or inflammatory diseases or cancers |